SCHEMBL6844852

SCHEMBL6844852

NCCOc1c(-c2ccoc2)ccc(CS(=O)(=O)c2ccc(F)cc2)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 15/20 0.50
FABP4 P15090 1/20 0.33
FABP5 Q01469 1/20 0.33
POLB P06746 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
ALOX5AP P20292 1/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1648721 0.99 METAP2 (0.49) METAP2FABP4FABP5POLBPSEN1
SCHEMBL1649388 0.91 METAP2 (0.39) METAP2FABP4FABP5ALOX5AP
Hydrochloric Acid SCHEMBL1648336 0.90 METAP2 (0.39) METAP2FABP4FABP5ALOX5AP
SCHEMBL6844903 0.87 METAP2 (0.39) METAP2FABP4FABP5ALOX5AP
SCHEMBL18784216 0.87 METAP2 (0.41) METAP2FABP4FABP5ALOX5AP
Hydrochloric Acid SCHEMBL1648362 0.87 METAP2 (0.39) METAP2FABP4FABP5ALOX5AP
SCHEMBL1648074 0.86 METAP2 (0.66) METAP2FABP4FABP5POLBTUBB4A
SCHEMBL6844846 0.84 METAP2 (0.36) METAP2FABP4FABP5
SCHEMBL1648728 0.83 METAP2 (0.41) METAP2FABP4FABP5ALOX5AP
SCHEMBL1649176 0.83 METAP2 (0.49) METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP disclosed
US-9067905-B2 Sulphone compounds and methods of making and using same ZAFGEN, INC. (US) 2015-06-30 US disclosed
US-9067905-B2 Sulphone compounds and methods of making and using same ZAFGEN, INC. (US) 2015-06-30 US disclosed
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same ZAFGEN, INC. 2013-02-28 US disclosed
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same ZAFGEN, INC. 2013-02-28 US disclosed
WO-2011044506-A2 SULPHONE COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN CORPORATION (US) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same METAP2, DNPEP, STS METAP2 1/4885FABP4 415/4885FABP5 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.